Diagnosis of Amniotic Fluid Embolism

Diagnosing amniotic fluid embolism remains challenging due to its rapid onset, nonspecific symptoms, lack of specific diagnostic tests, and overlap with other obstetric emergencies such as pulmonary embolism, anaphylaxis, severe preeclampsia, or septic shock. 

Clinical Presentation

Sudden Cardiovascular Collapse: The hallmark of amniotic fluid embolism is an abrupt drop in blood pressure, often accompanied by tachycardia or bradycardia, that may quickly progress to cardiac arrest. The cardiovascular collapse is primarily due to right ventricular failure secondary to pulmonary vasoconstriction or obstruction.

Hypoxemia and Respiratory Distress: Respiratory failure is another early sign of amniotic fluid embolism, with patients experiencing severe dyspnea, hypoxemia, and cyanosis. These symptoms are typically caused by pulmonary vasospasm and acute right heart failure.

Disseminated Intravascular Coagulation (DIC): In many cases, amniotic fluid embolism is associated with profound coagulopathy, leading to widespread hemorrhage. Coagulation abnormalities may manifest as bleeding from the uterus, surgical sites, or intravenous access points, and rapid correction of clotting factors is often necessary.

Seizures or Altered Mental Status: In some cases, neurologic symptoms, including seizures, confusion, or coma, may occur due to hypoxic encephalopathy from inadequate oxygenation or cerebral emboli.

The four clinical features of amniotic fluid embolism and the conditions that must be excluded.

Diagnostic Tests and Imaging

While amniotic fluid embolism is primarily diagnosed based on clinical presentation, several laboratory tests and imaging studies can help exclude other causes of cardiovascular collapse and support the diagnosis of amniotic fluid embolism:

Arterial Blood Gas (ABG): ABG will show severe hypoxemia, acidosis, and hypercarbia in amniotic fluid embolism patients. However, these findings are nonspecific and may be present in other causes of maternal respiratory distress.

Coagulation Studies: Coagulation profiles in amniotic fluid embolism patients often reveal a pattern consistent with DIC, such as elevated D-dimer levels, prolonged prothrombin time (PT), partial thromboplastin time (PTT), and low fibrinogen levels. Thrombocytopenia is also commonly seen.

Echocardiography: the bedside transthoracic echocardiography often reveals acute right ventricular dilation, pulmonary hypertension, and impaired right ventricular contractility, all indicative of right-sided heart failure.

Chest X-ray: will show evidence of pulmonary edema, although this is not specific to amniotic fluid embolism and may overlap with other conditions, such as pulmonary embolism or preeclampsia.

Amniotic Fluid Components in Blood: Histological identification of fetal squamous cells or amniotic fluid components, such as mucin or trophoblastic cells, in the maternal circulation or at autopsy has been used as a confirmatory test for amniotic fluid embolism. However, this is not routinely available in the acute setting and is often used retrospectively.